-
Forward Look
Cancer Immunotherapies Continue to Make HeadwayDrugs that harness the power of the immune system gain new approvals.
by Alexandra Goho
-
Big Data: Sharing Information to Improve Care
Big data, using high-powered computers to gather and analyze massive amounts of patient information, promises to revolutionize cancer care. But experts say patient concerns about privacy and other issues must be addressed.
by Stephen Ornes
-
Forward Look
Your Neighborhood, YourselfQ&A with Reginald Tucker-Seeley on the link between neighborhoods and cancer.
by Sue Rochman
-
Forward Look
The Right MatchNew NCI clinical trial will link patients to drugs that target their tumors.
by Whitney L.J. Howell
-
Forward Look
Childhood Cancer Survivors at Risk for Hormone DeficienciesNew study highlights importance of survivorship care.
by Sharon Reynolds
-
Forward Look
Identifying Ovarian Cancer RiskStudy may help spotlight women who would benefit from risk reduction strategies.
by Carrie Printz
-
First Person
To Test or Not to TestTwenty-two years after the first of two breast cancer diagnoses, a survivor decides to undergo genetic testing.
by Cynthia Ryan
-
Breaking the Blood-Brain Barrier
Advances in treating brain metastases and reducing their side effects are bringing new hope to cancer patients.
by Sue Rochman
-
Colorectal Cancer: A Troubling Trend
More people are being diagnosed with colorectal cancer before 50, the recommended age to start screening.
by Charlotte Huff
-
Healthy Habits
Pile on the VeggiesA study evaluates whether a change in diet could slow prostate cancer growth.
by Melinda Mahaffey Icden
Cancer Talk
Declining Breast Cancer Mortality in Younger Women
U.S. breast cancer deaths declined for women ages 20 to 49, which researchers credit to wider screening and better treatment.
by Kevin McLaughlin
Missed Activities Due to Cancer-related Fatigue and DepressionWomen were more likely than men to have fatigue or depression linked to cancer, and both effects were linked to people withdrawing from physical activities.
by Eric Fitzsimmons
Immunotherapy Improves Results in Head and Neck CancerCombining an immune checkpoint inhibitor with standard care extended event-free survival by nearly two years.
by Thomas Celona
Federal Support for Cancer Research Takes the Stage at AACR Annual MeetingScientists and former administrators gather for session focused on advocating for cancer research in uncertain times.
by Kevin McLaughlin